Skip Navigation

Person Details: Liwei Weng

Superfund Research Program

Liwei Weng

University of Pennsylvania
Department of Systems Pharmacology and Translational Therapeutics 853 BRB
421 Curie Boulevard
Philadelphia, Pennsylvania 19104
Phone: 215-573-9885
Email: wengl@upenn.edu

Publications

2019

2018

  • Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Mesaros C, Lynch DR, Blair IA. 2018. Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes. Sci Rep 8(1):17043. doi:10.1038/s41598-018-35346-y PMID:30451920 PMCID:PMC6242848
  • Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA. 2018. Liquid chromatography-high resolution mass spectrometry analysis of platelet frataxin as a protein biomarker for the rare disease Friedreich's ataxia. Anal Chem 90:2216-2223. doi:10.1021/acs.analchem.7b04590 PMID:29272104 PMCID:PMC5817373
  • Mazaleuskaya LL, Salamatipour A, Sarantopoulou D, Weng L, FitzGerald GA, Blair IA, Mesaros C. 2018. Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS. J Lipid Res 59:564-575. doi:10.1194/jlr.D081414 PMID:29301865 PMCID:PMC5832923
  • Weng L, Guo L, Vachani A, Mesaros C, Blair IA. 2018. Quantification of serum high mobility group box 1 by liquid chromatography/high-resolution mass spectrometry: Implications for its role in immunity, inflammation, and cancer. Anal Chem 90:7552-7560. doi:10.1021/acs.analchem.8b01175 PMID:29791130

2017

  • Blair IA, Wang Q, Guo L, Weng L, Salimatipour A, Hwang W, Lynch DR, Mesaros C. 2017. Systems pharmacology approach to the study of mitochondrial dysfunction. Abstr Pap Am Chem Soc 254:2.
  • Hinderer C, Katz N, Louboutin J, Bell P, Tolar J, Orchard PJ, Lund TC, Nayal M, Weng L, Mesaros C, de Souza CF, Corte AD, Giugliani R, Wilson JM. 2017. Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis. Hum Mol Genet 26(19):3837-3849. doi:10.1093/hmg/ddx277 PMID:28934395 PMCID:PMC5886077
  • Mesaros C, Blair IA, Weng L. 2017. Biomarkers of response to asbestos exposure. Chapter 12 in: Asbestos and Mesothelioma. Springer International Publishing, pp.259-277.
  • Xu R, Mesaros C, Weng L, Snyder NW, Vachani A, Blair IA, Hwang W. 2017. Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure. Biomark Med 11:547-556. doi:10.2217/bmm-2017-0087 PMID:28534416 PMCID:PMC5619144

2016

  • Vazquez-Medina J, Dodia C, Weng L, Mesaros C, Blair IA, Feinstein SI, Chatterjee S, Fisher AB. 2016. The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages. FASEB J 30(8):2885-2898. doi:10.1096/fj.201500146R PMID:27178323 PMCID:PMC4970605
Back
to Top